Basic information
Biomarker: PP14
Histology type: endometrioid endometrial carcinoma
Cohort characteristics
Country: UK
Region: Sheffield
Followed up time :
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
165 | pre- and post-menopausal women with bleeding problems | 139 | normal post-menopausal control women without bleeding | 26 |
Sample information
Conclusion: Elevated PP14 concentrations are also associated with the presence of endometrial adenocarcinoma and may have a potential to be used as a marker for this disease.
Sample type : plasma
Sample method: radioimmunoassay
Expression pattern : elevated concentrations
Disease information
Related information
Funtion Uniprot: Glycoprotein that regulates critical steps during fertilization and also has immunomonomodulatory effects. Four glycoforms, namely glycodelin-S, -A, -F and -C have been identified in reproductive tissues that differ in glycosylation and biological activity. Glycodelin-A has contraceptive and immunosuppressive activities (PubMed:9918684, PubMed:7531163). Glycodelin-C stimulates binding of spermatozoa to the zona pellucida (PubMed:17192260). Glycodelin-F inhibits spermatozoa-zona pellucida binding and significantly suppresses progesterone-induced acrosome reaction of spermatozoa (PubMed:12672671). Glycodelin-S in seminal plasma maintains the uncapacitated state of human spermatozoa (PubMed:15883155).
UniProt ID: P09466
UniProt Link: https://www.uniprot.org/uniprotkb/P09466/entry
Molecular function from UniProt:
Tissue specificity from UniProt: This protein is, the main protein synthesized and secreted in the endometrium from mid-luteal phase of the menstrual cycle and during the first semester of pregnancy (PubMed:3667877). Glycodelin-A is expressed in amniotic fluid, endometrium/decidua and maternal serum (at protein level) (PubMed:3194393). Glycodelin-F is expressed in follicular fluid, luteinized granulosa cells and the oviduct (at protein level) (PubMed:12672671). Glycodelin-S is expressed in seminal plasma and seminal vesicles (at protein level) (PubMed:9239694). Glycodelin-C is detected in cumulus cells (at protein level), but cumulus cells do not synthesize Glycodelin-C but take up and convert glycodelin-A and -F vis glycan remodeling (PubMed:17192260).
Subcellular UniProt: #Secreted
Alternative name from UniProt:
Recommended name: Glycodelin
Gene name from HGNC: PAEP (GD, GdA, GdF, GdS, MGC138509, MGC142288, PAEG, PEP, PP14)
AlphaFold DB: P09466
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/P09466
HPA link: https://www.proteinatlas.org/ENSG00000122133-PAEP
Tissue specificity RNA from HPA: Tissue enhanced (cervix, endometrium)
Tissue expression from HPA: Selective cytoplasmic expression in decidual cells and a subset of uterine glands.
Single cell type specificity Cell type enriched (Glandular and luminal cells)
Immune cell specificity: Group enriched (basophil, neutrophil)
Cancer prognostic summary HPA Prognostic marker in renal cancer (unfavorable), liver cancer (unfavorable) and stomach cancer (unfavorable)
Pathology link: https://www.proteinatlas.org/ENSG00000122133-PAEP/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000122133-PAEP/pathology/endometrial+cancer
OMIM: 173310
OMIM link2: https://www.omim.org/entry/173310
HGNC ID: HGNC:8573
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:8573